Literature DB >> 22845763

Vaccination status of children considered for renal transplants: missed opportunities for vaccine preventable diseases.

Gurkan Genc1, Ozan Ozkaya, Canan Aygun, Yarkin Kamil Yakupoglu, Hulya Nalcacioglu.   

Abstract

OBJECTIVES: Infectious diseases, even vaccine preventable ones, might affect transplanting and the life course in pediatric solid-organ recipients. Owing to immunosuppression and decreased antibody production, susceptibility to infections is increased in these patients.
MATERIALS AND METHODS: The present study was designed to assess the vaccination and antibody status of the pediatric renal transplant patients. Fifty-one patients who were admitted to the regional transplant center for renal transplant were retrospectively evaluated. Patient 's vaccination charts were examined, and their immunization status was determined by antibody titers against hepatitis B, hepatitis A, measles, mumps, rubella, and varicella.
RESULTS: The study group was composed of 23 males and 28 females (mean age, 10.8 y; age range, 2-17 y). All patients ' vaccination status was appropriate with their ages according to national vaccination program. Antibodies were positive for hepatitis B in 84.3% patients, 76.5% for hepatitis A, 72.5% for measles, 64.7% for mumps, 64.7% for rubella, and 72.5% for varicella.
CONCLUSIONS: Seronegativity for common childhood diseases may complicate the posttransplant period owing to increased risk of infections. Especially in developing countries, immunization protocols and vaccination program schedules should be reviewed before transplant to prevent serious complications caused by these diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22845763     DOI: 10.6002/ect.2012.0059

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  6 in total

1.  Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy.

Authors:  Britta Höcker; Martin Aguilar; Paul Schnitzler; Lars Pape; Martin Bald; Jens König; Stephen D Marks; Gurkan Genc; Anja Büscher; Markus J Kemper; Heiko Billing; Martin Pohl; Luca Dello Strologo; Nicholas J A Webb; Susanne Rieger; Annette Mankertz; Kai Krupka; Thomas Bruckner; Alexander Fichtner; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2018-01-10       Impact factor: 3.714

2.  Immunogenicity of the meningococcal polysaccharide conjugate vaccine in pediatric kidney transplant patients.

Authors:  Delphine R Nelson; Jeffrey Fadrowski; Alicia Neu
Journal:  Pediatr Nephrol       Date:  2018-03-20       Impact factor: 3.714

3.  Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation.

Authors:  Britta Höcker; Martin Aguilar; Paul Schnitzler; Lars Pape; Luca Dello Strologo; Nicholas J A Webb; Martin Bald; Gurkan Genc; Heiko Billing; Jens König; Anja Büscher; Markus J Kemper; Stephen D Marks; Martin Pohl; Marianne Wigger; Rezan Topaloglu; Susanne Rieger; Kai Krupka; Thomas Bruckner; Alexander Fichtner; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2017-10-05       Impact factor: 3.714

4.  Viral seroprevalence in pediatric kidney transplant recipients.

Authors:  Gülşah Kaya Aksoy; İmran Sağlık; Sevtap Velipaşaoğlu; Gözde Öngüt; Elif Çomak; Mustafa Koyun; Sema Akman
Journal:  Turk Pediatri Ars       Date:  2020-12-16

5.  Vaccinations in children on immunosuppressive medications for renal disease.

Authors:  Sushmita Banerjee; Pathum Vindana Dissanayake; Asiri Samantha Abeyagunawardena
Journal:  Pediatr Nephrol       Date:  2015-10-08       Impact factor: 3.651

6.  Varicella encephalitis and pneumonia in a patient with end stage renal failure.

Authors:  Lian Leng Low; Farhad Fakhrudin Vasanwala; Sufi Muhammad Suhail
Journal:  Asia Pac Fam Med       Date:  2014-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.